证据内容以英文维护。

Bottom line

"Focus, Stress & Sleep Blend" is a clinic-marketed name for a Semax + Selank + DSIP mixture. The identified listing claims a 10/10/2 mg composition, but a single clinic formulation does not define a standard. No published study of this exact three-component combination was identified.

No established or recommended human dose. The claimed 10/10/2 amount is a market observation, not guidance.

Name and formulation variability

Observed source/dateClaimed componentsClaimed amountsVerification limits
Beverly Hills Rejuvenation Center (2026)Semax, Selank, DSIP10 / 10 / 2 mgClinic-declared market observation; identity and contents not independently verified

Only one named formulation was identified. That is insufficient to establish either multi-vendor standardization or a stable market definition.

Component evidence

ComponentSeparate evidenceEvidence for combinationCompatibility/stability evidence
SemaxSee component monographNone identified for this three-component setNone identified
SelankSee component monographNone identified for this three-component setNone identified
DSIPSee component monographNone identified for this three-component setNone identified

Combination-specific studies

No published peer-reviewed study testing the exact Semax + Selank + DSIP mixture was identified. The clinic page documents a marketed formulation only.

Safety and interaction uncertainties

  • No combination-specific human safety, interaction, , or toxicology data were identified.

  • A three-component mixture complicates attribution of any unexpected effect.

  • Identity, purity, sterility, and co-formulation stability cannot be inferred from clinic marketing.

  • The stability of the three peptides together was not established by the supplied source.

Regulatory and product-quality notes

  • "Focus, Stress & Sleep Blend" is not a regulatory or pharmacopoeial formulation name.

  • A clinic listing is low-quality evidence for market observation and does not establish efficacy, safety, approval, or product quality.

  • Exact product and jurisdiction must be evaluated separately from the marketing name.

Evidence gaps

  • No second independent formulation source

  • No controlled combination study

  • No independent identity or content verification

  • No published compatibility or stability data

Sources

  1. Beverly Hills Rejuvenation Center. Semax, Selank & DSIP Blend clinic page. https://bhrcenter.com/peptides/semax-selank-dsip-blend/ accessed 2026-08-08.

  2. Beverly Hills Rejuvenation Center. Peptide services overview. https://bhrcenter.com/peptides/ accessed 2026-08-08.

专家观点

专家怎么说

评论属于个人观点,并非证据审查的一部分;收录不代表认可。

在本图谱接受的来源中 — 同行评审文献、大学、医院和医学会的通讯、监管机构以及署名科学新闻 — 未找到该化合物经过验证的专家评论。

评论缺失并不构成对该化合物有利或不利的证据。

供应商、诊所和社交媒体的声明根据政策被排除在外,不计入评论。

在本图谱的来源中未找到该化合物经过验证的专家视频。

视频评论缺失并不构成对该化合物有利或不利的证据。

供应商和社交媒体的视频根据政策被排除在外,不计入评论。

问题

What is in the Focus, Stress & Sleep Blend?

The identified clinic listing names Semax, Selank, and DSIP. That listing documents one claimed formulation, not a general market standard.

Is the Semax, Selank, and DSIP mixture standardized?

No. Only one named clinic formulation was identified, which is insufficient to establish a stable definition or independent corroboration.

Has the exact Focus, Stress & Sleep combination been studied?

No published peer-reviewed study testing the exact three-component mixture was identified. The clinic page is a market observation, not research evidence.

Can evidence for Semax, Selank, or DSIP validate the mixture?

No. Separate component findings cannot establish the safety, compatibility, interactions, or performance of the combined product.

What product-quality questions remain for this three-component blend?

Independent evidence for identity, content, purity, sterility, compatibility, and co-formulation stability was not identified.